Table 1 The antibiotic susceptibility patterns of the tested bacteria
Isolate code | Inhibition zone in mm (susceptibility pattern) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Meropenem | Ceftriaxone | Cefpodoxime | Cefotaxime< | Aztronam< | Amikacin | Piperacillin- tazobactam | Ceftazidime< | Ciprofloxacin | Cefepime | |
E1 | 24 (S) | 0 (R) | 0 (R) | 0 (R) | 22 (S) | 17(S) | 22(S) | 17(R) | 22(S) | 25(S) |
E2 | 23 (S) | 0(R) | 0 (R) | 0 (R) | 27 (s) | 13(R) | 23(S) | 15(R) | 25(S) | 28(S) |
E3 | 24 (S) | 0(R) | 0 (R) | 0 (R) | 22(S) | 18(S) | 26(S) | 23(S) | 30(S) | 28(S) |
E4 | 30(S) | 22(I) | 21 (S) | 22(R) | 28(S) | 23(S) | 28(S) | 24(S) | 30(S) | 30(S) |
E5 | 28(S) | 26(S) | 23 (S) | 21(R) | 24(S) | 24(S) | 30(S) | 24(S) | 32(S) | 27(S) |
E6 | 28 (S) | 25(S) | 22 (S) | 29(S) | 24(S) | 22(S) | 25(S) | 21(S) | 30(S) | 29(S) |
E7 | 29(S) | 26(S) | 23(S) | 22(R) | 27(S) | 25(S) | 26(S) | 24(S) | 30(S) | 27(S) |
E8 | 24 (S) | 11(R) | 0 (R) | 15 (R) | 22(S) | 18(S) | 24(S) | 18(I) | 25(S) | 25(S) |
E9 | 26 (S) | 22(I) | 15(R) | 0(R) | 24(S) | 16(I) | 26(S) | 27(S) | 24(S) | 26(S) |
E10 | 23 (S) | 0(R) | 0 (R) | 0(R) | 20(I) | 18(S) | 22(S) | 17(R) | 22(S) | 25(S) |
E11 | 27(S) | 23(S) | 23 (S) | 22(R) | 28(S) | 27(S) | 28(S) | 26(S) | 29(S) | 30(S) |
K1 | 23(S) | 13(R) | 9(R) | 19(R) | 21(S) | 17(S) | 23(S) | 22(S) | 22(S) | 27(S) |
K2 | 20(I) | 10(R) | 0(R) | 10(R) | 18(I) | 14(R) | 24(S) | 17(R) | 26(S) | 16(R) |
K3 | 21(I) | 0(R) | 0 (R) | 0(R) | 20(I) | 17(S) | 22(S) | 21(S) | 26(S) | 17(R) |
P | 0(R) | 0(R) | 0 (R) | 0(R) | 15(R) | 17(S) | 13(R) | 12(R) | 18(I) | 14 (R) |